(Q48875721)

16 February 2018

editorial

0 references

review article

1 reference

title

The eternal triangle: benefit, risk, and cost of therapeutic agents. (English)

1 reference

16 February 2018

author name string

Simons FE

series ordinal

1

1 reference

16 February 2018

publication date

1 November 1996

1 reference

16 February 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

16 February 2018

volume

77

1 reference

16 February 2018

issue

5

1 reference

16 February 2018

page(s)

337-340

1 reference

16 February 2018

The pharmacology and use of H1-receptor-antagonist drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

1 reference

7 January 2021

An overview of current pharmacotherapy in perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

The pharmacokinetics and antihistaminic effects of brompheniramine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Nasal pharmacodynamics of brompheniramine in perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Clinical experience with parabromdylamine maleate (dimetane), a new antihistaminic

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Brompheniramine, terfenadine, and placebo in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Oral Facial Dyskinesia Associated with Prolonged Use of Antihistaminic Decongestants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Differences in performance impairment due to brompheniramine maleate as a function of the sustained-release system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

A histamine-containing neuronal system in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Optimum treatment of rhinitis in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

H1-receptor antagonists. Comparative tolerability and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: A C-EEG study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Sleepiness and performance during three-day administration of cetirizine or diphenhydramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Studies on the central effects of the H1-antagonist, loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

The effects of terfenadine with and without alcohol on an aspect of car driving performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Comparison of the central nervous system effects produced by six H1-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

The effects of phenindamine tartrate on sleepiness and psychomotor performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963330-3

7 January 2021

10.1016/S1081-1206(10)63330-3

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018